chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tinnitus, dizziness, nausea, rapid heart rate, excessive thirst, woozy or loopy feeling, instability, numbness and tingling in fingers, cramps in chest. All symptoms resolved within a few weeks except tinnitus which is relentless.
I experienced feeling  fatigue and extremely cold for a period of a few hours, I then took a NSAID and drank hot liquid and the feeling slowly subsided.
I'm nursing.  My son started throwing up at 9pm the Tuesday following my dose of the Pfizer vaccine.  He threw up for 4 hours straight.  Wouldn't eat or drink, could keep anything down.  He was 13 months and 24 days at the time.
I had a lot of coughing and pain in my lower back that I couldn?t lie down to sleep. I went to get tested for COVID-19, RSV, and the flu, and I was negative for all of them. They did a chest x-ray and it was inconclusive for Pneumonia so the doctor put me on Azithromycin. The symptoms didn?t get better so I went to the emergency room on 01/11/2023. They admitted me to the hospital and they did further testing. I don?t remember if it was a CT scan or MRI but it showed I had extensive pulmonary embolism on both sides. They preceded to treat me with blood thinners. Afterwards they put me on Eliquis. The other potentially complicating factor around the time of my admission to the hospital is that I was using another drug for weight loss, which is called Sexenda. However, the hematologist and general practitioner don?t believe there is a connection to the pulmonary embolism.
Pt recvd Typhoid vax instead of flu vax & subsequently devel swelling & inflammation @ inject site, chest congestion & tightness, cough, fever, h/a, full-body rash, & stomach cramps;
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hashimotos" (unspecified if ongoing); "Known allergies: YES" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever of 100, abdominal cramping/pain. Very tired (in bed from 9am  on 8/11/2020 until 3:00pm - unable to work or perform daily house routines.
pt recv vax & exp urticaria & a generalized rash over most of the body;
Vomiting, headache, chills, myalgias ("achy all over, especially her arm), onset about 12 hours after vaccine administration
Employee states "Fuzzy skin", chills, weakness, headache, injection sight soreness. Treatment is resting in bed with fan to cool off.
severe chronic cough; pain in the stomach; fatigue; slight fever; pain in the joints; pain in the injection site; This spontaneous case was reported by an other caregiver and describes the occurrence of COUGH (severe chronic cough), ABDOMINAL PAIN UPPER (pain in the stomach), FATIGUE (fatigue), PYREXIA (slight fever) and ARTHRALGIA (pain in the joints) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (pain in the stomach), FATIGUE (fatigue), PYREXIA (slight fever), ARTHRALGIA (pain in the joints) and VACCINATION SITE PAIN (pain in the injection site). On 17-Mar-2021, the patient experienced COUGH (severe chronic cough). On 11-Mar-2021, ABDOMINAL PAIN UPPER (pain in the stomach), FATIGUE (fatigue), PYREXIA (slight fever), ARTHRALGIA (pain in the joints) and VACCINATION SITE PAIN (pain in the injection site) had resolved. At the time of the report, COUGH (severe chronic cough) had not resolved.            Concomitant medication was not reported.  Treatment information was not reported.   This case was linked to MOD-2021-163376 (Patient Link).
first day: body aches sore throat enlarged lymph nodes fever nausea lethargic rash on chest second day: back pain dizziness short of breath weakness lethargic brown urine abdominal pain lethargic third day: sore throat enlarged lymph nodes loss of taste and smell joint pain lethargic fourth day. hip pain enlarged lymph nodes lethargic over all not feeling well. 5th day: lethargic and not feeling well
myalgias, severe HA, dizziness, and ST. Tried OTC NSAIDS with no relief.  THV with provider on 3/30/21.
Fever; This is a solicited report from consumer (patient) via Pfizer AbbVie Inc. (Mfr. Control No.21K-163-3855391-00). A 71-year-old female patient received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiry date: unknown) intramuscular, administered at an unspecified anatomical location on an unknown date (age at vaccination was 71 years) at a single dose for Covid-19 immunisation. On 02Mar2021 (ongoing) patient started treatment with ibrutinib (IMBRUVICA), orally at 1x/day (420 mg,1 in 1) for chronic lymphocytic leukemia. Concomitant medication were not reported. There was no reported medical history. In 2021, the patient experienced Fever with IMBRUVICA (IBRUTINIB). COVID-19 VACCINE was also considered suspect. It was unknown if the patient was enrolled in a COVID-19 Vaccine Trial. The causality for ibrutinib (IMBRUVICA) was not reported. The reporter's causality for the event of fever was not provided. The outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After receiving DTaP on 10/03/2001 client leg progressively became more swollen and tender. Dad brought client to clinic on 10/15/2001. MD examined left thigh which was red, hot, swollen and painful to touch.
Patient came in for second dose today. Not given as she states after the first one she had a large area of redness and swelling to right arm and had a day of fever and flu like symptoms. Resolved after 24-48 hours.
The patient did not report any AEs; Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours; Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours) and NO ADVERSE EVENT (The patient did not report any AEs) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7171B) for COVID-19 prophylaxis.     Concurrent medical conditions included Immunocompromised.    On 16-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 16-May-2023, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours) and POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours). On an unknown date, the patient experienced NO ADVERSE EVENT (The patient did not report any AEs). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours) and NO ADVERSE EVENT (The patient did not report any AEs) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (The patient did not report any AEs) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours) and POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 Vaccine Bivalent experienced a temperature excursion during about 2 hours).    No concomitant medication details was reported. No treatment medication details was reported.
Myalgia, CoughWheeze, Syncope, POSTIVE COVID test 7/22/2021 Narrative: POSITIVE COVID Test 7/22/2021
Chills, fatigue, myalgias, sinus pressure, sharp lower back pain with radiation to knees, left TMJ pain
Shoulder very sore, continuing to have numbness and tingling down the arm and into my hand.  Have seen doctor and chiropractor.  Painful to move arm up and down or for example putting arm in coat.
Sore arm. A week later arm got a big red patch, itchy and raised and hot to touch. It kept growing to the size of her hand. Tired,  Saw a doctor and was prescribed prednisone. It has started to go down.
I have an autoimmune disorder that causes a rash, muscle aches, weakness and fatigue.  I haven't had a flare-up in quite some time.  Two days after I received the shot, I started with the rash, aches and some fatigue.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Muscle cramps and allodynia Narrative:  Woke today joint pain, HA, 100.5 vomiting. Body ache, HA, Zofran. Able to drink a bit. Bad leg cramps last night extended to whole body. Knees and hips particularly bad. Ibu and Tylenol First dose no problems. Allodynia.- dog licking her leg feels like razor blades
itchy patch on her back; This is a spontaneous report from a contactable consumer (patient). A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient initially asked if the Pfizer's vaccine cover against the new variants, and she wanted to know how long after the second dose the vaccine is fully effective. The patient reportedly developed an itchy patch on her back two and a half weeks after her first dose of the Pfizer BioNTech Covid 19 vaccine. She still has this itchy patch and is going to a dermatologist. The patient asked if this was from the vaccine. The outcome of the event was not resolved. The event required a Physician Office Visit.   No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
NO ADVERSE EVENTS REPORTED, BUT PATIENT RECEIVED A DOSE FROM A VIAL THAT HAD BEEN PUNCTURED AND SAT AT ROOM TEMPURATURE FOR 77 HOURS.  PATIENT IS AWARE AND PHARMACIST IS AWAITING GUIDANCE FROM MODERNA ON WHETHER OR NOT ANOTHER DOSE IS NEEDED.
Episode of chest pain around 0100 this morning, elevated troponin in ER NSTEMI vs. possible perimyocarditis
pt stated that she felt dizzy shortly after covid 19 Pfizer vaccine. Patient has been drinking Gatorade and symptoms did not resolve after about 30 minutes.  Asked mother to see if she wanted us to call 911. Mother requested us to call then paramedics came.  Paramedics checked blood pressure, oxygen and glucose levels and everything came back within normal limits.  Paramedics advised mom to either keep an eye on her at home or take her to emergency room.  Mom said she will take the patient to ER.  Paramedics helped the patient leave the store.
A child received vaccines on 2/10/00. That evening developed a fever of 103 and pain in the left leg. Went to ER and was diagnose with UTI and given Cephalexin. On 2/11/00 the child was unable to walk on left leg. Mom denies redness or swelling to the left thigh injection site. Mom instructed to treated with Tylenol and cold packs. Follow up 2/12/00, the pt complained of left leg pain, left  thigh was swollen, erythema in the skin and painful by palpation at injection site. Assessment is skin reaction to immunization.
Tested positive for Coronavirus; Tested positive for Coronavirus; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 25Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant) with onset 25Oct2021, outcome "unknown", described as "booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested positive for Coronavirus". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Patient got the booster of Pfizer Covid Vaccine on 25Oct2021 and tested positive for Coronavirus on Monday-he did not specify which Monday/date.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt developed red swelling about palm-sized on left arm (adm. site) x1 day post injection. 11 days later pt said it turned black and blue, pain upon touching. Pt will see PCP in 6 days to elevate.
left arm is reddened area 55m x 55 mm states ears are itchy + throat is sore. redness - immediate ears +throat - 24 hours later
fever 102+ 4 inch diameter red, swollen circle around injection site with additional areas of red "streaks" body aches, headache, fatigue
Started feeling tingling to face and closing to throat some nausea, zero dizziness, zero SOB except feeling throat is still closing 10:18 Benadryl given IM 10:20 epinephrine
Developed shingles virus after receiving the vaccine. This is a spontaneous report from a non-contactable consumer or other non-healthcare professional (Patient). A 31-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient not tested for COVID-19, post vaccination. The patient developed shingles virus after receiving the vaccine on 06Aug2021. The event caused physician office visit/ other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles. The patient received unspecified treatment medication for event. The outcome of event reported as recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
FLU-LIKE SYMPTOMS; NAUSEA; INJECTION SITE SWELLING; This spontaneous report received from a consumer concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 2021, the subject experienced flu-like symptoms, nausea and injection site swelling. The action taken with covid-19 vaccine  was not applicable. The outcome of the flu-like symptoms, nausea and injection site swelling was not reported. This report was non-serious.
Mom brought pt to ER c/o "won't pee" however voided mod amt prior to coming to ER & voided 50-60cc's in ER;  Had fever on 12MAY & had been crying, whiney since 11MAY & was eating poorly, had watery diarrhea 3-4x day; t96.9; dx oliguria
pt recvd vax & devel papules on the palms of both hands; sx persisted for 1 day & recovered; No further details were provided;
4/27/15 Reports that had more right arm discomfort than left through the day after vaccine given. The evening began to notice swelling with raised redness with also 3 circular red areas on right shoulder; describes as "welt like and itchy". Also noted on left arm "above the elbow and between the elbow and forearm, has two separate patchy red areas", but nothing at the injection site. The arm soreness improved by 4/26/15 and better on 4/27/15. Denied and shortness of breath or other sx. Was instructed to go to see a Dr. Reports on 5/14/15 that had f/u with a Dr. and received a steroid injection on 4/27/15. on 5/14/15 reports that later an area appeared on the left deltoid and that the areas are "slowly going away but still notices a different skin pigmentation where the lesions were. Denies other complaints.
Patient received Pfizer COVID vaccine on 1/29/2021 and 1/8/2021.   On 3/29/2021 the patient developed fever, cough, rhinorrhea, body aches, headache, shortness of breath, and nausea.  Tested positive for COVID.
The case was received on 21 March 2014. Initial misuse report received from a healthcare professional on 18 October 2013. A 16-months-old patient had received 0.5 ml dose of FLUZONE on an unspecified date instead of the age appropriate 0.25 ml dose. No adverse event was reported. List of documents held by sender: none.
Severe local reaction to immunization (DTaP). Rt arm swollen from shoulder to below elbow. Skin red, blotchy. No decrease in movement. Pain and itching 24 hrs post immun. Arm feels tight, sl hard and warm.
3 hrs after administration began swelling and tender to touch, 6 hrs after admin started fever. 24 hrs after red and still tender.
Bullous pemphigoid; This literature-study case was reported in a literature article and describes the occurrence of PEMPHIGOID (Bullous pemphigoid) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    The patient's past medical history included Atopic dermatitis (Childhood).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PEMPHIGOID (Bullous pemphigoid) (seriousness criterion medically significant). The patient was treated with PREDNISONE (oral) for Adverse event, at an unspecified dose and frequency. At the time of the report, PEMPHIGOID (Bullous pemphigoid) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Biopsy skin: abnormal (abnormal) Intraepidermal spongiotic  vesicles with  eosinophilic  spongiosis. In 2021, Immunology test: abnormal (abnormal) linear deposition of C3 and weak linear deposition of Immunoglobulin (IgG) along the dermoepidermal junction confirming a diagnosis of bullous pemphigod.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PEMPHIGOID (Bullous pemphigoid) to be possibly related.    Concomitant medications were not provided by the reporter.   It was reported that the clinical and histopathologic features of delayed cutaneous adverse reactions from 12 patients after receiving an mRNA COVID-19 vaccine. Patient reported no recent medication changes who developed a widespread eruption of erythematous papules and plaques, some with vesiculation two week after second dose of Moderna vaccine  Treatment drug included topical corticosteroids.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-276439, MOD-2021-276440, MOD-2021-276441, MOD-2021-276442, MOD-2021-276443, MOD-2021-276444, MOD-2021-276445, MOD-2021-276353, MOD-2021-278847 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Doctors are suspecting I might have mucous or blood colitis, we are just not sure; Hands, both right-left hand and wrist, right-left foot and ankles and toes, heels, right-left knees are numb; Burning sensation; Doctors are suspecting I might have mucous or blood colitis, we are just not sure; Shooting pain like flu; This is spontaneous report from contactable consumer (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, (patient not sure if it's right arm or left arm) on 13Mar2021 (Batch/Lot Number: EP7534) as 1ST DOSE, SINGLE, for covid-19 immunisation. The patient took the second dose on 04Apr2021 (Batch/Lot Number: ER8732). The patient medical history and concomitant medications were not reported. The patient stated that "I wanted to report about suspected side effects to covid-19 shot. I'm not sure if it's the Covid-19 shot or not or has to do with it but I wanted it to be documented may there's some coincidence, you can tell me about. All extremities hands, both right-left hand and wrist, right-left foot and ankles and toes, heels, right-left knees are numb. Burning sensation, shooting pain kind of like flu but no body temperature change, body temperature is 97.7 down there, it's been occurring now past my 2nd shot." The patient later corrected it as," It's 5-10 days after the 1st shot." When paraphrased, the consumer stated," I've got a number of doctors working on trying to figure out what's wrong with me. So, if we cannot find anymore answers then I'm sure, I'll contact Pfizer. I don't know if it has anything to do with the shot or not, I don't even know if the side-effects are from Pfizer or not. Doctors are suspecting I might have mucous or blood colitis, we are just not sure." When asked for the anatomical Site of administration of Vaccine: The patient stated, "I'm not sure if it's my right arm or left arm." For the event start date: patient stated, "18 or 19 June, somewhere around there. I am not sure. (pending clarification)" The patient also added: "Do you guys also report to VAERS? I don't know my physician asked to say, if you guys report to VAERS, otherwise I should call VAERS and report my symptoms." The outcome of the events was unknown.   Information on the Lot/Batch number has been requested.
Lymph node swelling like normally described on CDC website. Started 3 days after vaccine and subsided a few days after each shot. However lymph node swelling came back even more intense 6 weeks after first shot cause 13 lymph nodes in armpit to become super swollen red and painful. Some symptoms have decreased however still have swelling and pain in the left arm and then pain and swelling began in right arm this past week.